J Reconstr Microsurg 2007; 23(5): 269-274
DOI: 10.1055/s-2007-985208
© Thieme Medical Publishers

Flap Monitoring by Transcutaneous PO2 and PCO2: Importance of Transcutaneous PCO2 in Determining Follow-up Treatment for Compromised Free Flaps

Ichiro Hashimoto1 , Hideki Nakanishi1 , Hirotsugu Takiwaki2 , Maki Toda Takase1 , Masahiro Yamano1 , Hiromichi Sedo1
  • 1Department of Plastic and Reconstructive Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
  • 2Department of Dermatological Science, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
Further Information

Publication History

Publication Date:
18 September 2007 (online)

Preview

ABSTRACT

The authors conducted a two-part study to determine whether transcutaneous oxygen pressure (TcPO2) and transcutaneous carbon dioxide pressure (TcPCO2) can be used to monitor flap viability after transplantation. The first part was an animal study in which TcPO2 and TcPCO2 were measured in 10 epigastric island flaps subjected to arterial or venous ischemia. The second part was a clinical study in which both were measured in 27 free skin flaps. In the experimental study, TcPO2 decreased to nearly 0 mmHg after 10 minutes of arterial and venous ischemia. TcPCO2 increased to 100 mmHg after 60 minutes of either type of ischemia. In the clinical study, congestion was suspected in six flaps on the basis of clinical signs alone. Three congested flaps with TcPCO2 more than 90 mmHg were selected for intervention. The remaining three congested flaps, with TcPCO2 80 mmHg or less, survived completely without further treatment. The TcPO2 of all treated flaps and of the six flaps not requiring further treatment was 0 mmHg. Results of experimental study indicate that TcPO2 is more sensitive than TcPCO2 to flap ischemia. However, results of clinical study suggest that it is very hard to distinguish congested flaps from healthy flaps by TcPO2 alone. The authors believe that a congested flap with a TcPCO2 more than 90 mmHg requires further treatment.

REFERENCES

Ichiro HashimotoM.D. 

Department of Plastic and Reconstructive Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School

Kuramoto-cho, Tokushima 770-8503, Japan